SCHEMBL10119286

SCHEMBL10119286

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3C=CCN3OCCc3ccccn3)cc2)cc1)[C@@H]1CCCN1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN3A Q9NY46 3/20 0.39
SCN9A Q15858 2/20 0.39
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35
JAK2 O60674 2/20 0.35
PDGFRB P09619 2/20 0.35
FLT3 P36888 2/20 0.35
IKBKB O14920 1/20 0.35
KIT P10721 1/20 0.35
PDGFRA P16234 1/20 0.35
FLT1 P17948 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10119337 0.75 ADRB1 (0.36) HDAC1FPR3FPR2CYP3A4EPHX2
SCHEMBL873706 0.73 PFKFB2 (0.42) SCN3ASCN9AHDAC3HDAC4HDAC1
SCHEMBL845510 0.72 SCN3A (0.54) SCN3ASCN9AHDAC3HDAC4HDAC1
SCHEMBL871886 0.72 SCN3A (0.39) SCN3ASCN9AHDAC3HDAC4HDAC1
SCHEMBL845190 0.71 EPHX2 (0.42) MEN1NPC1RAB9AKMT2AFPR3
Hydrochloric Acid SCHEMBL16741983 0.71 SCN3A (0.52) SCN3ASCN9AHDAC3HDAC4HDAC1
Hydrochloric Acid SCHEMBL16741981 0.71 SCN3A (0.52) SCN3ASCN9AHDAC3HDAC4HDAC1
SCHEMBL873383 0.69 CHRNA7 (0.36) HDAC1KMT2AFPR3FPR2
SCHEMBL10119480 0.69 GAA (0.39) SCN3ASCN9AHDAC3HDAC4HDAC1
SCHEMBL845086 0.69 EPHX2 (0.40) MEN1NPC1RAB9AKMT2AFPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed